Congress Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100M Buy
190,193
+23,507
+14% +$13.2M 0.62% 61
2026
Q1
$93.7M Buy
166,686
+12,778
+8% +$8.19M 0.67% 49
2025
Q4
$104M Buy
153,908
+152,368
+9,894% +$104M 0.73% 44
2025
Q3
$984K Sell
1,540
-984
-39% -$597K 0.01% 319
2025
Q2
$1.35M Sell
2,524
-43
-2% -$20.6K 0.01% 303
2025
Q1
$1.08M Sell
2,567
-365
-12% -$158K 0.01% 305
2024
Q4
$1.21M Sell
2,932
-1,236
-30% -$542K 0.01% 306
2024
Q3
$2.11M Sell
4,168
-193
-4% -$93.8K 0.01% 274
2024
Q2
$2.12M Sell
4,361
-138
-3% -$69.3K 0.02% 275
2024
Q1
$2.43M Sell
4,499
-72
-2% -$39.3K 0.02% 269
2023
Q4
$2.54M Sell
4,571
-641
-12% -$301K 0.02% 282
2023
Q3
$2.28M Sell
5,212
-355
-6% -$177K 0.02% 275
2023
Q2
$2.8M Buy
5,567
+46
+0.8% +$22K 0.02% 261
2023
Q1
$2.76M Buy
5,521
+410
+8% +$196K 0.03% 259
2022
Q4
$2.09M Buy
5,111
+1,214
+31% +$471K 0.02% 283
2022
Q3
$1.27M Sell
3,897
-6,111
-61% -$2.24M 0.01% 294
2022
Q2
$3.51M Buy
10,008
+1,241
+14% +$506K 0.03% 240
2022
Q1
$4.8M Sell
8,767
-5,466
-38% -$2.88M 0.04% 233
2021
Q4
$9.37M Sell
14,233
-7,188
-34% -$4.51M 0.07% 175
2021
Q3
$13.3M Sell
21,421
-200,180
-90% -$135M 0.1% 116
2021
Q2
$140M Sell
221,601
-1,798
-0.8% -$993K 1.17% 29
2021
Q1
$109M Sell
223,399
-4,118
-2% -$2.06M 0.99% 47
2020
Q4
$114M Sell
227,517
-9,787
-4% -$4.38M 1.07% 41
2020
Q3
$93.3M Sell
237,304
-558
-0.2% -$206K 1.01% 45
2020
Q2
$78.5M Buy
237,862
+15,809
+7% +$4.58M 0.93% 56
2020
Q1
$53.8M Buy
222,053
+220,935
+19,762% +$57.7M 0.82% 68
2019
Q4
$292K Hold
1,118
﹤0.01% 329
2019
Q3
$304K Hold
1,118
﹤0.01% 328
2019
Q2
$308K Sell
1,118
-220
-16% -$54.2K ﹤0.01% 332
2019
Q1
$299K Sell
1,338
-49
-4% -$10.1K ﹤0.01% 338
2018
Q4
$258K Hold
1,387
﹤0.01% 350
2018
Q3
$346K Hold
1,387
﹤0.01% 346
2018
Q2
$302K Sell
1,387
-253
-15% -$52.1K ﹤0.01% 348
2018
Q1
$314K Sell
1,640
-263
-14% -$48.5K ﹤0.01% 360
2017
Q4
$298K Sell
1,903
-175
-8% -$27.5K ﹤0.01% 359
2017
Q3
$323K Sell
2,078
-98
-5% -$15.5K 0.01% 370
2017
Q2
$351K Sell
2,176
-42
-2% -$6.82K 0.01% 238
2017
Q1
$343K Sell
2,218
-410
-16% -$56.5K 0.01% 235
2016
Q4
$308K Buy
2,628
+112
+4% +$12.8K 0.01% 240
2016
Q3
$284K Sell
2,516
-208
-8% -$21.9K 0.01% 211
2016
Q2
$253K Sell
2,724
-465,567
-99% -$40M 0.01% 215
2016
Q1
$36.7M Buy
468,291
+24,107
+5% +$1.74M 0.89% 49
2015
Q4
$32.4M Sell
444,184
-5,969
-1% -$426K 0.8% 53
2015
Q3
$33.4M Buy
450,153
+146,582
+48% +$10.5M 0.86% 46
2015
Q2
$19.5M Sell
303,571
-68,983
-19% -$4.78M 0.56% 77
2015
Q1
$28.8M Buy
372,554
+69,388
+23% +$5.4M 0.69% 56
2014
Q4
$22.5M Sell
303,166
-79,902
-21% -$5.6M 0.57% 51
2014
Q3
$22.6M Buy
383,068
+35,142
+10% +$2.22M 0.58% 59
2014
Q2
$23.2M Buy
347,926
+12,700
+4% +$808K 0.59% 50
2014
Q1
$20.3M Buy
335,226
+106,164
+46% +$6.32M 0.51% 57
2013
Q4
$12.2M Sell
229,062
-53,502
-19% -$2.82M 0.32% 69
2013
Q3
$14.1M Buy
282,564
+13,814
+5% +$664K 0.39% 66
2013
Q2
$12.1M Buy
+268,750
New +$11.7M 0.36% 68

Other funds holding IDXX

Congress Asset Management's IDXX Position: Q2 2026 in Review

Congress Asset Management increased its Idexx Laboratories (IDXX) stake by 14% in Q2 2026, buying an estimated $13.2M and bringing the position to 190,193 shares worth $100M. The position accounts for 0.62% of the portfolio, ranked #61.

Congress Asset Management first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $140M in Q2 2021. 173 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Congress Asset Management held 190,193 shares of Idexx Laboratories worth $100M as of Q2 2026.
  • Congress Asset Management bought 23,507 Idexx Laboratories shares in Q2 2026, an estimated $13.2M.
  • Idexx Laboratories made up 0.62% of Congress Asset Management's portfolio in Q2 2026, its #61 holding.
  • Congress Asset Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Congress Asset Management's Idexx Laboratories position peaked at $140M in Q2 2021.
  • 173 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.